Terms ending in 2030
Every in-force patent on Merial, Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,426,460 | Dimeric Avermectin and Milbemycin Derivatives In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 8,871,225 | Canine Leishmania Vaccine In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 9,050,338 | Morpholino Compound Microemulsion In force · High confidence | Merial Limited | In force | High confidence | |
| US 7,980,200 | Ectoparasite Diagnostic Apparatus and Method of Use Thereof In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 8,097,266 | Solvent Systems for Pour-On Formulations for Combating Parasites In force · Medium confidence | Merial, Inc. | In force | Medium confidence | |
| US 9,616,118 | Newcastle Disease Virus Vectored Avian Vaccines In force · Medium confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | Medium confidence | |
| US 10,350,286 | Newcastle Disease Virus Vectored Avian Vaccines In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 10,487,334 | Antibiotic-Free Plasmid In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 8,314,218 | Method of Synthesizing Macrolide Compounds In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 8,734,430 | Sustained Release Capsules In force · High confidence | Merial, Inc. | In force | High confidence | |
| 8 more term ends in 2030 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
15 of these are in force and held by Merial, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.